Name: Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness (Video) | JoVE Journal
Uploaded: 2018-05-03T13:30:00.000+00:00
Duration: 5 min 51 s
Description: Learn a standardized tonometry-based method to measure carotid-femoral pulse wave velocity for assessing arterial stiffness in human patients. This protocol ensures accurate, reproducible cardiovascular diagnostics.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work is under the financial support from National key research and development program of China (Grant No. 2017YFC0111800) and the Shanghai municipal government (Grant ID. 2013ZYJB0902 and 15GWZK1002). Dr. Yi Zhang was supported by the National Nature Science Foundation of China (Grant ID. 81300239 and 81670377).

This protocol was approved by the Ethics Committee of Shanghai Tenth People&#39;s Hospital.
1. Recruitment of Participants
<ol>
	<li>Include Adults with a moderate heart rate (40 &#60; HR &#60; 160).</li>
	<li>Use the following exclusion criteria.
	<ol>
		<li>Exclude those without internal arteriovenous fistula for renal dialysis or any other peripheral arteriovenous fistula like that.</li>
		<li>Exclude those without peripheral arterial spasm, for example the Raynaud disease.</li>
		<li>Exclude those without aortic valvular stenosis (transprosthetic pressure gradient &#62; 60 mmHg).</li>
		<li>Exclude those without second or third-degree atrioventricular (AV) block.</li>
		<li>Exclude those without atrial fibrillation or atrial flutter.</li>
		<li>Exclude those without unstable carotid atherosclerotic plaques that may rupture after kneading. 9) Without cognitive impairment or unable to cooperate.</li>
	</ol>
	</li>
	<li>Ensure that the participants&#39; bladder is empty.</li>
	<li>Have participants refrain from smoking, tobacco use or caffeine use for at least 3 hours before the measurement. Abstain from alcohol for at least 12 hours before the measurement. Fast for at least 3 hours before the measurement.</li>
</ol>
2. Measurements of Vascular TOD
NOTE: cf-PWV and PWA measurements, like conventional four-limb blood pressure measurements, are performed through a non-invasive evaluating method. A standard protocol is crucial to obtain an accurate value, especially when there are multiple operators. Make sure to practice the method before the actual operation. The participant&#39;s cooperation is key for the measurement of cf-PWV.
<ol>
	<li>Explain the procedure to the participant and obtain permission.</li>
	<li>Measure the body height and weight before the start of the measurements.</li>
	<li>Explain that the process may take 5-10 min and involves letting the participant lie on the bed.
	<ol>
		<li>Keep the patient&#39;s skin clean and dry when shifting supine positions. If the patient&#39;s skin is damp because of sweating, then wipe dry the skin.</li>
		<li>Perform the measurements in a quiet room with a stable room temperature.</li>
	</ol>
	</li>
	<li>Put the participant&#39;s hands next to their body to make sure there is a smooth, undisturbed ECG signal. Connect up to 3-lead ECG monitors, positioning three electrodes (RA, LL, LA) according to the following diagram (Figure 2). 
	NOTE: The use of disposable electrodes is recommended. The ECG leads and wires cannot be used in other ECG drawing equipment.</li>
	<li>Have the patient rest for at least 5 minutes in the supine position. Then measure the patient&#39;s blood pressure with a semiautomatic oscillometric device. 
	NOTE: The blood pressure is measured according to the recommendations of the European Society of Hypertension17.</li>
	<li>Have the patient rest for at least 2 minutes. 
	NOTE: The peripheral vascular dilatation caused by artery occlusion when measuring brachial artery blood pressure will change the brachial artery pulse transmission. Resting is essential to avoid excessive deviation.</li>
	<li>While the participant rests, enter the participant&#39;s detailed information, including the supine blood pressure, body height, body weight and operator&#39;s name, into the measurement device (Figure 3).</li>
	<li>After entering all the information, keep the participants in a supine position.</li>
	<li>Manually measure the following parameters (mm) (Figure 3).
	<ol>
		<li>Measure the distance from the suprasternal notch (SSN) to the remote detection point (femoral artery).</li>
		<li>Measure the distance from the sternal notch to the proximal (carotid artery) detection point.</li>
		<li>Measure the distance from the remote detection point (femoral artery) to the proximal (carotid artery) detection point (cf-distance).</li>
	</ol>
	</li>
	<li>Choose the PWA mode. Enter &#39;0&#39; as SSN-carotid distance, and enter 0.8*cf-distance as SSN-femoral distance. If the device doesn&#39;t accept &#39;0&#39;, put another value as the SSN-carotid distance and add that value to the 80% cf distance as SSN-femoral distance5. 
	NOTE: The operator should sit in a most comfortable position.</li>
	<li>Press the button to capture data. Put the tonometer on the radial artery fluctuation point (1-2 cm above the radial styloid process at a point where the fluctuation is strong and stable) to measure the central blood pressure.
	<ol>
		<li>Maintain the position of the tonometer to obtain a steady waveform on the computer. Once the quality and reproducibility of the tonometry measurements reach the standard, the signal recording is finished automatically by the computer.</li>
		<li>Keep the tonometer at 90&#176;.</li>
		<li>To avoid parasite movement, immobilize the tonometer near the base with the fingers, firmly affix the tonometer to the skin. 
		NOTE: The software automatically records the data as soon as the tonometer is placed in contact with the measurement site. The quality and reproducibility of the tonometry measurements are automatically tested. An operator index greater than 80% is considered as a reliable measurement. Pulse pressure amplification (PPA) is defined as the peripheral-to-central pulse pressure ratio and is calculated with the formula, PPA= (brachial SBP- brachial DBP)/ (central SBP- central DBP)-1. PWA can be observed on the device18 (Figure 4).</li>
	</ol>
	</li>
	<li>Choose the PWV mode. Put the tonometer on the carotid artery fluctuation point. Maintain the position of the tonometer to obtain a steady waveform on the computer. After recording a stable waveform for 15-20 seconds. Once the quality and reproducibility of the tonometry measurements reach the standard, finish recording manually (Figure 5).</li>
	<li>Put the tonometer on the femoral artery fluctuation point (1-2 cm below the midpoint of the inguinal ligament at a point where the fluctuation is stable). Maintain the position of the tonometer to record a steady waveform. After recording a stable waveform for 15-20 seconds, finish recording manually once the quality and reproducibility of the tonometry measurements reach the standard. The PWV value can be observed on the device cf-PWV &#8805; 10 m/s is considered as arterial stiffening (Figure 5)1.</li>
</ol>

<ol><li>Laurent, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Expert+consensus+document+on+arterial+stiffness%3A+methodological+issues+and+clinical+applications%5BTitle%5D)+AND+%22Eur+Heart+J%22%5BJournal%5D)">Expert consensus document on arterial stiffness: methodological issues and clinical applications.</a> Eur Heart J. 27 (21), 2588-2605 (2006).</li>
<li>Townsend, R. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Recommendations+for+Improving+and+Standardizing+Vascular+Research+on+Arterial+Stiffness%3A+A+Scientific+Statement+From+the+American+Heart+Association%5BTitle%5D)+AND+%22Hypertension%22%5BJournal%5D)">Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association.</a> Hypertension. 66 (3), 698-722 (2015).</li>
<li>Niiranen, T. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Prevalence%2C+Correlates%2C+and+Prognosis+of+Healthy+Vascular+Aging+in+a+Western+Community-Dwelling+Cohort%3A+The+Framingham+Heart+Study%5BTitle%5D)+AND+%22Hypertension%22%5BJournal%5D)">Prevalence, Correlates, and Prognosis of Healthy Vascular Aging in a Western Community-Dwelling Cohort: The Framingham Heart Study.</a> Hypertension. 70 (2), 267-274 (2017).</li>
<li>Reference Values for Arterial Stiffness, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Determinants+of+pulse+wave+velocity+in+healthy+people+and+in+the+presence+of+cardiovascular+risk+factors%3A+%27establishing+normal+and+reference+values%5BTitle%5D)+AND+%22Eur+Heart+J%22%5BJournal%5D)">Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values.</a> Eur Heart J. 31 (19), 2338-2350 (2010).</li>
<li>Van Bortel, L. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Expert+consensus+document+on+the+measurement+of+aortic+stiffness+in+daily+practice+using+carotid-femoral+pulse+wave+velocity%5BTitle%5D)+AND+%22J+Hypertens%22%5BJournal%5D)">Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity.</a> J Hypertens. 30 (3), 445-448 (2012).</li>
<li>Salvi, P. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aSalvi%2C+P+%22Pulse+waves%3A+how+vascular+hemodynamics+affect+blood+pressure%22">Pulse waves: how vascular hemodynamics affect blood pressure</a>. , Springer. (2011).</li>
<li>Mancia, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((2013+ESH%2FESC+Guidelines+for+the+management+of+arterial+hypertension%3A+the+Task+Force+for+the+management+of+arterial+hypertension+of+the+European+Society+of+Hypertension+%28ESH%29+and+of+the+European+Society+of+Cardiology+%28ESC%29%5BTitle%5D)+AND+%22J+Hypertens%22%5BJournal%5D)">2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).</a> J Hypertens. 31 (7), 1281-1357 (2013).</li>
<li>Yamashina, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Validity%2C+reproducibility%2C+and+clinical+significance+of+noninvasive+brachial-ankle+pulse+wave+velocity+measurement%5BTitle%5D)+AND+%22Hypertens+Res%22%5BJournal%5D)">Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement.</a> Hypertens Res. 25 (3), 359-364 (2002).</li>
<li>Tanaka, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Comparison+between+carotid-femoral+and+brachial-ankle+pulse+wave+velocity+as+measures+of+arterial+stiffness%5BTitle%5D)+AND+%22J+Hypertens%22%5BJournal%5D)">Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness.</a> J Hypertens. 27 (10), 2022-2027 (2009).</li>
<li>Lu, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Comparison+of+Carotid-Femoral+and+Brachial-Ankle+Pulse-Wave+Velocity+in+Association+With+Target+Organ+Damage+in+the+Community-Dwelling+Elderly+Chinese%3A+The+Northern+Shanghai+Study%5BTitle%5D)+AND+%22J+Am+Heart+Assoc%22%5BJournal%5D)">Comparison of Carotid-Femoral and Brachial-Ankle Pulse-Wave Velocity in Association With Target Organ Damage in the Community-Dwelling Elderly Chinese: The Northern Shanghai Study.</a> J Am Heart Assoc. 6 (2), (2017).</li>
<li>D'Agostino, R. B. Sr, et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((General+cardiovascular+risk+profile+for+use+in+primary+care%3A+the+Framingham+Heart+Study%5BTitle%5D)+AND+%22Circulation%22%5BJournal%5D)">General cardiovascular risk profile for use in primary care: the Framingham Heart Study.</a> Circulation. 117 (6), 743-753 (2008).</li>
<li>Conroy, R. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Estimation+of+ten-year+risk+of+fatal+cardiovascular+disease+in+Europe%3A+the+SCORE+project%5BTitle%5D)+AND+%22Eur+Heart+J%22%5BJournal%5D)">Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.</a> Eur Heart J. 24 (11), 987-1003 (2003).</li>
<li>Zethelius, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Use+of+multiple+biomarkers+to+improve+the+prediction+of+death+from+cardiovascular+causes%5BTitle%5D)+AND+%22N+Engl+J+Med%22%5BJournal%5D)">Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.</a> N Engl J Med. 358 (20), 2107-2116 (2008).</li>
<li>Vernooij, J. W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hypertensive+target+organ+damage+and+the+risk+for+vascular+events+and+all-cause+mortality+in+patients+with+vascular+disease%5BTitle%5D)+AND+%22J+Hypertens%22%5BJournal%5D)">Hypertensive target organ damage and the risk for vascular events and all-cause mortality in patients with vascular disease.</a> J Hypertens. 31 (3), 492-499 (2013).</li>
<li>van der Veen, P. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hypertensive+Target+Organ+Damage+and+Longitudinal+Changes+in+Brain+Structure+and+Function%3A+The+Second+Manifestations+of+Arterial+Disease-Magnetic+Resonance+Study%5BTitle%5D)+AND+%22Hypertension%22%5BJournal%5D)">Hypertensive Target Organ Damage and Longitudinal Changes in Brain Structure and Function: The Second Manifestations of Arterial Disease-Magnetic Resonance Study.</a> Hypertension. 66 (6), 1152-1158 (2015).</li>
<li>Ji, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Shanghai+Study%3A+cardiovascular+risk+and+its+associated+factors+in+the+Chinese+elderly-a+study+protocol+of+a+prospective+study+design%5BTitle%5D)+AND+%22BMJ+Open%22%5BJournal%5D)">Shanghai Study: cardiovascular risk and its associated factors in the Chinese elderly-a study protocol of a prospective study design.</a> BMJ Open. 7 (3), (2017).</li>
<li>O'Brien, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Practice+guidelines+of+the+European+Society+of+Hypertension+for+clinic%2C+ambulatory+and+self+blood+pressure+measurement%5BTitle%5D)+AND+%22J+Hypertens%22%5BJournal%5D)">Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement.</a> J Hypertens. 23 (4), 697-701 (2005).</li>
<li>Agnoletti, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pulse+wave+analysis+with+two+tonometric+devices%3A+a+comparison+study%5BTitle%5D)+AND+%22Physiol+Meas%22%5BJournal%5D)">Pulse wave analysis with two tonometric devices: a comparison study.</a> Physiol Meas. 35 (9), 1837-1848 (2014).</li>
<li>Ji, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Shanghai+Study%3A+cardiovascular+risk+and+its+associated+factors+in+the+Chinese+elderly-a+study+protocol+of+a+prospective+study+design%5BTitle%5D)+AND+%22BMJ+Open%22%5BJournal%5D)">Shanghai Study: cardiovascular risk and its associated factors in the Chinese elderly-a study protocol of a prospective study design.</a> BMJ Open. 7 (3), e013880(2017).</li>
<li>Zhang, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Comparison+study+of+central+blood+pressure+and+wave+reflection+obtained+from+tonometry-based+devices%5BTitle%5D)+AND+%22Am+J+Hypertens%22%5BJournal%5D)">Comparison study of central blood pressure and wave reflection obtained from tonometry-based devices.</a> Am J Hypertens. 26 (1), 34-41 (2013).</li>
<li>Sharman, J. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Validation+of+non-invasive+central+blood+pressure+devices%3A+ARTERY+Society+task+force+consensus+statement+on+protocol+standardization%5BTitle%5D)+AND+%22Eur+Heart+J%22%5BJournal%5D)">Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization.</a> Eur Heart J. 38 (37), 2805-2812 (2017).</li>
<li>Millasseau, S., Agnoletti, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Non-invasive+estimation+of+aortic+blood+pressures%3A+a+close+look+at+current+devices+and+methods%5BTitle%5D)+AND+%22Curr+Pharm+Des%22%5BJournal%5D)">Non-invasive estimation of aortic blood pressures: a close look at current devices and methods.</a> Curr Pharm Des. 21 (6), 709-718 (2015).</li>
<li>Olsen, M. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+call+to+action+and+a+lifecourse+strategy+to+address+the+global+burden+of+raised+blood+pressure+on+current+and+future+generations%3A+the+Lancet+Commission+on+hypertension%5BTitle%5D)+AND+%22Lancet%22%5BJournal%5D)">A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension.</a> Lancet. 388 (10060), 2665-2712 (2016).</li>
</ol>

The authors have nothing to disclose.

Here, we demonstrate a widely accessible methodology to assess the participants&#39; novel preclinical vascular TOD, arterial stiffness, evaluated by cf-PWV. In order to compare PWs with minimal hemodynamic differences between measurements done prior to devices, only accept data when the brachial systolic and diastolic BP varied by less than 3 mmHg. This reduces the deviation caused by human manipulation. In this protocol, the critical steps are to have standardized patient conditions using 80% of the direct straight dis...

Arterial stiffening is a good marker for vascular aging evaluation1,2. The measurement of arterial stiffening is traditionally conducted using a pulse wave velocity (PWV) methodology that is an important and reliable measure of arterial stiffness1,3,4,5. Specifically, PWV represents the stiffness of a specific arterial segment. The pulse wave is transmitted through the arterial vessels in a specific segment, and its speed is inversely related to the viscoelastic properties of the wall itself6. PWV value increases with arterial stiffening.
Carotid-femoral PWV (cf-PWV) and brachial-ankle PWV (ba-PWV) are the 2 most frequently applied PWV measurements. They are widely used in clinical practice, where cf-PWV is popular in western countries and ba-PWV is popular in Asian countries.7,8. In fact, cf-PWV has been considered as the &#39;gold-standard&#39; measurement of arterial stiffness1. For cf-PWV, it is taken as representative of the PWV for the entire aorta. Besides, for ba- PWV, there is no true arterial pathway linking the measurement sites (brachial to ankle). The estimated ba-PWV represents the PWV for the entirety of the central and peripheral arterial system9. A previous study has reported that cf-PWV is superior to ba-PWV in associations with asymptomatic hypertensive target organ damage (TOD)10 (Figure 1).
Non-invasive devices for regional stiffness equipped with a specific tonometer are increasingly being used to measure the stiffness of the carotid to femoral segment1. In cf-PWV measurements, this device and a handheld tonometer create a steady waveform on the computer that can record high resolution digital waveform images and the specific PWV values (Figure 2). All these measurements need to be standardized. Here, we show how to record a good quality cf-PWV with this non-invasive tonometry-based device in a real-world setting.
Some established cardiovascular risk prediction models such as the Framingham risk score and the SCORE Risk Charts are mainly calculated and sorted by conventional risk factors11,12. However, some novel biomarkers should be added into the risk assessment model to improve the risk stratification13. In literature, arterial stiffening is considered as an intermediate state between conventional risk factors and clinical cardiovascular events14. Thus, adding cf-PWV into the risk assessment model may be a tool for risk stratification15,16.
Here, we generate a methodology plan to assess participants&#39; cf-PWV, together with PWA, to establish a standard protocol for arterial stiffening assessment.

<table><tbody><tr><td>SphygmoCor tonometry-based device</td><td>AtCor Medical, Australia</td><td></td><td>For central blood pressures and cf-PWV</td></tr><tr><td>Electrodes</td><td>AtCor Medical, Australia</td><td></td><td>To record the ECG</td></tr><tr><td>Semiautomatic Oscillometric device</td><td>OMRON Healthcare, kyoto, Japan</td><td></td><td>To measure brachial BP</td></tr></tbody></table>

measuring the carotid to femoral pulse wave velocity (cf-pwv) to evaluate arterial stiffness

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness

For the elderly, arterial stiffening is a good marker for aging evaluation and it is recommended that the arterial stiffness be determined noninvasively by the measurement of carotid to femoral pulse wave velocity (cf-PWV) (Class I; Level of Evidence A). In literature, numerous community-based or disease-specific studies have reported that higher cf-PWV is associated with increased cardiovascular risk. Here, we discuss strategies to evaluate arterial stiffness with cf-PWV. Following the well-defined steps detailed here, e.g., proper position operator, distance measurement, and tonometer position, we will obtain a standard cf-PWV value to evaluate arterial stiffness. In this paper, a detailed stepwise method to record a good quality PWV and pulse wave analysis (PWA) using a non-invasive tonometry-based device will be discussed.

Cf-PWV (with this method) and ba-PWV (with other method10) were conducted in all of the 2098 participants from Northern Shanghai Study19. Both cf-PWV and ba-PWV were used in the same logistic regression model. In this model, age and gender were adjusted. The results showed that only cf-PWV, but not ba-PWV, was significantly associated with increased IMT and arterial plaque, which indicates the superiority of cf-PWV over ba-PWV in the associa...

This protocol describes a method to standardize the measurements of carotid-femoral pulse wave velocity to evaluate arterial stiffness.

For the elderly, arterial stiffening is a good marker for aging evaluation and it is recommended that the arterial stiffness be determined noninvasively ...

measuring-carotid-to-femoral-pulse-wave-velocity-cf-pwv-to-evaluate

Research

JoVE Journal

Medicine

Pulse wave velocity (PWV) measurement assesses arterial stiffness by a tonometry-based system that measures the speed with which arterial pressure wave travels along the arterial tree, typically approximating the time that it takes this wave to travel from the descending aorta (using the carotid artery as a surrogate) to the femoral artery. Carotid-femoral PWV increases two- to threefold across the adult lifespan.

Pulse Wave Velocity Testing in the Baltimore Longitudinal Study of Aging

The degree of vascular dysfunction and contributing physiological mechanisms can be assessed in patients with chronic kidney disease by measuring brachial artery flow-mediated dilation, aortic pulse-wave velocity, and vascular endothelial cell protein expression.

Assessment of Vascular Function in Patients With Chronic Kidney Disease

We describe a technique for measuring aortic stiffness from its pressure-diameter relationship in vivo in mice. Aortic diameter is recorded by ultrasound and aortic pressure is measured invasively with a solid-state pressure catheter. Blood pressure is changed incrementally and the resulting diameter is measured.

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Arterial stiffness represents a key factor in cardiovascular disease and pulse wave velocity (PWV) can be considered as a surrogate index for arterial stiffness. This protocol describes an image processing algorithm for calculating PWV in mice based on ultrasound image processing that is applicable at different arterial sites.

Ultrasound-based Pulse Wave Velocity Evaluation in Mice

Endothelial/vascular aging and atherogenesis are key mechanisms that promote the development of cardiovascular diseases. The present protocol describes methods to evaluate arterial stiffness, endothelial dysfunction, and atherogenesis in patients with related risk factors, which are highly valuable in the cardiovascular research field.

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Amblyopia is a developmental disorder of the visual cortex that is often accompanied by strong suppression of one eye. We present a new technique for measuring and treating interocular suppression in patients with amblyopia that can be deployed using virtual reality goggles or a portable iPod Touch device.

The Measurement and Treatment of Suppression in Amblyopia

The mouse femoral artery wire injury model of restenosis is technically challenging. In this protocol we show the key technical details essential for successfully performing wire injury to induce consistent neointima for studies of restenosis.

A Murine Model of Arterial Restenosis: Technical Aspects of Femoral Wire Injury

This method is to introduce a transgene into the endothelium of rabbit carotid arteries. Introduction of the transgene allows the assessment of the biological role of the transgene product either in normal arteries or disease models. The method is also useful for measuring activity of DNA regulatory sequences.

In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium

Here, we present a protocol for a study comparing the efficacy, safety, and delivery of olive-oil-based 3CB and soybean-oil-based CoB formulations in adults requiring parenteral nutrition. The results revealed that olive-oil-based 3CBs is non-inferior and well tolerated compared to soybean formulations.

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

The goal of the protocol is to measure the extension range of motion of the rat knee. The effects of various diseases that increase the stiffness of the knee joint and the effectiveness of treatments can be quantified.

Using a Knee Arthrometer to Evaluate Tissue-specific Contributions to Knee Flexion Contracture in the Rat

Learn a standardized tonometry-based method to measure carotid-femoral pulse wave velocity for assessing arterial stiffness in human patients. This protocol ensures accurate, reproducible cardiovascular diagnostics.

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness

Explore More Videos